Welcome to our dedicated page for Celsius Hldgs SEC filings (Ticker: CELH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celsius Holdings, Inc. (NASDAQ: CELH) SEC filings page on Stock Titan provides a centralized view of the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Celsius Holdings is a Nevada corporation and functional beverage company whose common stock is listed on the Nasdaq Capital Market, and its filings offer detailed insight into its operations, capital structure and key transactions.
Among the most relevant documents for CELH are current reports on Form 8-K and 8-K/A, which the company uses to disclose material events. Recent 8-K filings describe acquisitions such as the purchase of Alani Nutrition LLC (Alani Nu) and the Rockstar Energy brand assets in the U.S. and Canada, amendments to distribution agreements with PepsiCo, preferred stock investments by PepsiCo, board appointments, share repurchase authorizations and earnings releases for quarterly periods.
Investors reviewing Celsius Holdings’ filings can also find information on its preferred stock terms, board designation rights granted to PepsiCo, credit facilities, potential refinancing activities and the use of non-GAAP financial measures like Adjusted EBITDA and Adjusted Diluted EPS. Amendments on Form 8-K/A provide additional details, including abbreviated financial statements for acquired businesses and unaudited pro forma condensed combined financial information.
On Stock Titan, CELH filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered tools summarize key points from lengthy filings, helping users quickly understand transaction terms, capital structure changes, distribution arrangements and other disclosures without reading every page of the underlying documents.
Celsius Holdings reported sizeable growth in the first half of 2025 driven by its April 1, 2025 acquisition of Alani Nu and strong North American sales. Revenue rose to $739.3 million for the quarter (from $402.0 million prior-year) and $1.07 billion for six months (from $757.7 million). Quarterly net income was $99.9 million, with net income attributable to common stockholders of $85.7 million and basic EPS of $0.33. Gross profit expanded to $380.9 million.
The balance sheet reflects the Acquisition: total assets increased to $3.795 billion from $1.767 billion, goodwill rose to $802.2 million, and indefinite-lived brands were recognized at $1.104 billion. The company drew a $900 million term loan (long-term debt net of discounts $862.9 million) to partially fund the acquisition and used cash on hand, reducing cash to $615.2 million. Promotional allowances and concentrations with a major distributor (Pepsi) remain material. Pro forma metrics show higher combined revenue and net income when Alani Nu is included for prior periods.
Celsius Holdings (CELH) filed a Form 144 notice covering the proposed sale of 7,900,000 common shares, equal to roughly 3.1 % of the 257.7 million shares outstanding. Based on the filing’s reference price, the block is valued at $404.3 million. Sales are expected to begin on or about 7 Aug 2025 through Citigroup Global Markets on Nasdaq.
The stock originated from two prior conversions: (1) 3.0 million shares issued on 12 Dec 2018 when a convertible note was exchanged, fully paid 19 Sep 2019, and (2) 2.103 million shares issued on 16 Apr 2015 from Series A preferred conversion. In the past three months the filing party, identified as CD Financial LLC, already sold 1.692 million shares for $77.8 million in gross proceeds.
Form 144 is only a notice and does not obligate execution, yet a sale of this magnitude by an early investor could create short-term supply pressure and be interpreted as profit-taking. No operational or earnings data accompanied the filing.
Celsius Holdings (CELH) Form 4 filed 08/04/2025 shows that 10% owner Dean DeSantis, acting as trustee for the Carl DeSantis Revocable Trust, sold 100,000 common shares on 07/31/2025 at $47.50 per share, generating roughly $4.8 million in proceeds. Post-sale, the trust still owns 17,717,770 shares indirectly through CDF, retaining a very large position. No derivative trades were reported.
The disposal equals about 0.6 % of the insider’s remaining stake, suggesting portfolio rebalancing rather than a strategic exit. Nevertheless, any sale by a major holder can be read as a sentiment cue; investors should monitor follow-on filings for trend confirmation.